Zurich Cantonal Bank’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $689K | Buy |
49,622
+924
| +2% | +$14.7K | ﹤0.01% | 1641 |
|
|
2025
Q4 | $791K | Buy |
48,698
+12,712
| +35% | +$207K | ﹤0.01% | 1489 |
|
|
2025
Q3 | $538K | Sell |
35,986
-565
| -2% | -$6.88K | ﹤0.01% | 1699 |
|
|
2025
Q2 | $426K | Sell |
36,551
-203
| -0.6% | -$1.84K | ﹤0.01% | 1761 |
|
|
2025
Q1 | $273K | Sell |
36,754
-15,521
| -30% | -$119K | ﹤0.01% | 1931 |
|
|
2024
Q4 | $313K | Buy |
+52,275
| New | +$288K | ﹤0.01% | 1918 |
|
|
2024
Q2 | – | Sell |
-21,364
| Closed | -$68.6K | – | 2642 |
|
|
2024
Q1 | $68.6K | Hold |
21,364
| – | – | ﹤0.01% | 2507 |
|
|
2023
Q4 | $105K | Buy |
21,364
+4,715
| +28% | +$21.5K | ﹤0.01% | 2431 |
|
|
2023
Q3 | $90.7K | Hold |
16,649
| – | – | ﹤0.01% | 2395 |
|
|
2023
Q2 | $112K | Hold |
16,649
| – | – | ﹤0.01% | 2297 |
|
|
2023
Q1 | $147K | Hold |
16,649
| – | – | ﹤0.01% | 2061 |
|
|
2022
Q4 | $127K | Buy |
16,649
+3,755
| +29% | +$29.2K | ﹤0.01% | 2119 |
|
|
2022
Q3 | $92K | Hold |
12,894
| – | – | ﹤0.01% | 2286 |
|
|
2022
Q2 | $104K | Hold |
12,894
| – | – | ﹤0.01% | 2205 |
|
|
2022
Q1 | $179K | Sell |
12,894
-951
| -7% | -$15K | ﹤0.01% | 1959 |
|
|
2021
Q4 | $388K | Buy |
13,845
+3,334
| +32% | +$102K | ﹤0.01% | 1642 |
|
|
2021
Q3 | $357K | Buy |
10,511
+11
| +0.1% | +$398 | ﹤0.01% | 1516 |
|
|
2021
Q2 | $429K | Buy |
10,500
+77
| +0.7% | +$2.99K | ﹤0.01% | 1312 |
|
|
2021
Q1 | $420K | Sell |
10,423
-1,156
| -10% | -$62.6K | ﹤0.01% | 1340 |
|
|
2020
Q4 | $685K | Buy |
11,579
+3,271
| +39% | +$169K | ﹤0.01% | 1111 |
|
|
2020
Q3 | $404K | Hold |
8,308
| – | – | ﹤0.01% | 1184 |
|
|
2020
Q2 | $402K | Buy |
+8,308
| New | +$303K | ﹤0.01% | 1119 |
|
Other funds holding ADPT
VCM
VPM
